Schizophrenia (SCZ)

Frontiers in Synaptic Regeneration: Tazbentetol for Schizophrenia

Tazbentetol for Schizophrenia Shows Symptom Improvement in Phase 2 Trial

Synaptic Regeneration: A New Frontier in Schizophrenia Treatment

Spinogenix Launches Phase II Trial for Synaptic Regenerative Therapy in Schizophrenia

Novel Schizophrenia Drug Explored; Daridorexant Treats Insomnia + Nocturia; ADHD Drug Trialed

Reset the Clock on Schizophrenia: SPG302, A Regenerative Treatment

Behind the Steering Wheel of Your Brain: Residual Negative and Cognitive Symptoms in Schizophrenia

Phase 2 Trial Open Enrollment for SPG302, First Synaptic Regenerative Approach to Treat Schizophrenia

SPG302: A Synaptic Regenerative Treatment Option for Schizophrenia

First Synaptic Regenerative Therapy for Schizophrenia Under Investigation